Peter C. Isakson
- Pharmacology top 0.01%
- Inflammatory mediators and NSAID effects 77
- Biochemistry top 0.05%
- Eicosanoids and Hypertension Pharmacology 23
- Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects 77
- Immunology top 1%
- T-cell and B-cell Immunology 21
- Immune Cell Function and Interaction 14
- Organic Chemistry top 0.5%
- Synthesis of β-Lactam Compounds 19
- Synthesis and biological activity 11
-
- Estrogen and related hormone effects 23
-
- Monoclonal and Polyclonal Antibodies Research 18
- Co-authors
- Karen SeibertJaime L. MasferrerScott D. HauserK. LeahyJames K. GierseGilbert GeisCarol M. KoboldtPhilip Needleman
- Cited by
- PharmacologyBiochemistry
- Journals
- The Journal of Immunology (17 papers)Proceedings of the National Academy of Sciences (10 papers)The Journal of Experimental Medicine (9 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Peter C. Isakson
134 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Pharmacology 9.2k
- Biochemistry 2.2k
- Pharmacology 1.3k
- Immunology 2.2k
- Organic Chemistry 2.8k
Countries citing papers authored by Peter C. Isakson
This map shows the geographic impact of Peter C. Isakson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Isakson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Isakson more than expected).
Fields of papers citing papers by Peter C. Isakson
This network shows the impact of papers produced by Peter C. Isakson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Isakson. The network helps show where Peter C. Isakson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter C. Isakson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 72 | |
| 2 | 2003 | 3 | |
| 3 | 2001 | 69 | |
| 4 | 1999 | 410 | |
| 5 | 1998 | 405 | |
| 6 | Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.breakdown → | 1997 | 627 |
| 7 | 1997 | 118 | |
| 8 | 1997 | 23 | |
| 9 | 1997 | 239 | |
| 10 | 1996 | 359 | |
| 11 | 1996 | 63 | |
| 12 | Novel 1,2-diarylcyclopentenes are selective, potent, and orally active cyclooxygenase inhibitors | 1995 | 10 |
| 13 | 1995 | 121 | |
| 14 | 1994 | 22 | |
| 15 | 1993 | 3 | |
| 16 | 1991 | 80 | |
| 17 | 1990 | 154 | |
| 18 | 1987 | 22 | |
| 19 | 1986 | 27 | |
| 20 | 1980 | 11 |
About Peter C. Isakson
Peter C. Isakson is a scholar working on Pharmacology, Biochemistry and Immunology, having authored 134 papers that have together received 16.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (77 papers), Eicosanoids and Hypertension Pharmacology (23 papers), Estrogen and related hormone effects (23 papers), T-cell and B-cell Immunology (21 papers), Synthesis of β-Lactam Compounds (19 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Immune Cell Function and Interaction (14 papers) and Synthesis and biological activity (11 papers). The work is most often cited by research in Pharmacology (9.2k citations), Biochemistry (2.2k citations) and Pharmacology (1.3k citations). Peter C. Isakson has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Karen Seibert, Jaime L. Masferrer, Scott D. Hauser, K. Leahy, James K. Gierse, Gilbert Geis, Carol M. Koboldt, Philip Needleman, Ben S. Zweifel and Walter E. Kaufmann. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Journal of Pharmacology and Experimental Therapeutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.